Skip to content

IBTI PHARMA

Active Private limited companyfounded 2021active for 5 yearsRue de l'Espinette (C.) 216, 7033 MonsKBO/BCE: BE 0769.814.863

Lifetime

4 annual accounts with figures on one time axis
peak of €277,172 in 2022
€79,831▲ 60.6%
peak of €200,872 in 2022
€28,266▲ 24.2%
peak of €315,706 in 2025
€315,706▲ 9.8%
€345,092▼ 11.3%
Board2 names since 2021
2 directors and 1 other
Documentsfilings and deeds
21-09-202652 days late
2025micro format
Gross margin from €49,719 to €79,831Cash from €16,276 to €27,757

Key points

from the 2025 annual accounts

Equity

€315,706 ▲ 9.8%

IBTI PHARMA has made a profit in every financial year since 2022.

Turnover

≈ €390,000 estimated

The micro format states no turnover.

Liquidity

0.79 was 0.31 in 2024

Short-term debts fell from €64,197 to €45,653.

Filings

4 annual accounts 2 late
AprilJune31 JulyOctober2022202320242025

The 2025 accounts came in latest, 52 days after the end of the period.

Position in the sector

€315,706

More equity than 91% of companies in retail trade. Sector median €40,791 · 25,439 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,638 companies had the same profile as IBTI PHARMA has now. Each dot stands for 5 companies, two years later.

95.4%
were still trading
3.7%
stopped another way
0.5%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.4% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,638 companies, not a prediction for IBTI PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • 100 sharesdeed of 07-09-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0769814863
appointed as director General meeting of 20-05-2024 · Gazette deed
Amendment of the articles Founding capital of €100, 100 shares · Founded by · appointed as director · Gazette deed
Incorporation Founding capital of €100, 100 shares · Founded by · Founder: · published on 21-06-2021 · Gazette deed
All 10 events

Comparable companies

same main activity, similar in size and age
Company
IBTI PHARMA Mons €660,797 €79,831 47.8% -
APOTHEEK ROTTI Antwerp €656,849 €83,396 33.1% -
LENA MALCORPS Sint-Truiden €704,130 €76,288 27.6% -
Pharmacie de BALMORAL Chaudfontaine €720,927 €86,171 0.7% -
APOTHEEK NEVEJAN De Panne €717,910 €86,526 25.5% 0.1
ASTELLA Bilzen-Hoeselt €603,476 €67,949 24.3% -
IGS PHARMA Sint-Gillis (bij-Brussel) €656,335 €86,248 -23.7% -

These companies have the same main activity as IBTI PHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €603,000 and €721,000, founded between 2019 and 2022.

Official details

Source: KBO
Status
Active since 17-06-2021Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment unit
2.362.430.3477033 Mons, since 17-06-2021
Financial year end
31 December
Peppol
Reachable since 02-03-2026
Company details

Annual accounts 2025

€660,797▼ 2.3%
Filing
Filed on 21-09-2026
Financials

Insights on IBTI PHARMA

IBTI PHARMA files the micro format. That format states no turnover. The gross margin fell from €277,172 in 2022 to €79,831 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about IBTI PHARMA

What is the company number of IBTI PHARMA?
The company number of IBTI PHARMA is 0769.814.863. The VAT number is the same number with BE in front: BE 0769.814.863.
Where is IBTI PHARMA based?
The registered office is at Rue de l'Espinette (C.) 216, 7033 Mons.Company details
What does IBTI PHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of IBTI PHARMA?
IBTI PHARMA is a private limited company (BV).
When was IBTI PHARMA founded?
IBTI PHARMA was founded on 17-06-2021.
Is IBTI PHARMA still active?
Yes, IBTI PHARMA is an active enterprise in the KBO register.
What is the turnover of IBTI PHARMA?
The turnover in financial year 2025 is ≈ €390,000. This figure is estimated from the gross margin of €79,831 and 54 comparable companies (NACE 477). It probably lies between €190,000 and €560,000.Financials
Is IBTI PHARMA profitable?
In financial year 2025, IBTI PHARMA made a profit of €28,266.
Where can I find the annual accounts of IBTI PHARMA?
IBTI PHARMA filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of IBTI PHARMA due?
IBTI PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.